News from merrimack pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 24, 2005, 01:00 ET

Merrimack Pharmaceuticals Announces the Addition of Two New Members to its Scientific Advisory Board

CAMBRIDGE, Mass., May 24 /PRNewswire/ -- Dan R. Littman, M.D., Ph.D. and James D. Marks, M.D., Ph.D have joined the Scientific Advisory Board...

May 03, 2005, 01:00 ET

Merrimack Pharmaceuticals Appoints Gary L. Crocker as Chairman of the Board

CAMBRIDGE, Mass., May 3 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a biotechnology company focused on the discovery and development of...

Apr 20, 2005, 01:00 ET

Merrimack Pharmaceuticals Closes on $37 Million of Series D Equity and Loan Financing

CAMBRIDGE, Mass., April 20 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that it has completed equity and debt financings...

Mar 03, 2005, 00:00 ET

Merrimack Pharmaceuticals Initiates Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis

CAMBRIDGE, Mass., March 3 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the initiation of a Phase 2 study of the safety and...

Aug 25, 2004, 01:00 ET

Merrimack Pharmaceuticals Completes Enrollment for Phase IIa Study of MM-093 in Patients with Rheumatoid Arthritis

CAMBRIDGE, Mass., Aug. 25 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the completion of enrollment for a Phase IIa pilot...

Jul 20, 2004, 01:00 ET

Merrimack Pharmaceuticals Names Dr. Brian L. Hamilton Vice President of Clinical and Regulatory Affairs

CAMBRIDGE, Mass., July 20 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that Brian L. Hamilton, M.D., Ph.D., has joined the...

Jun 01, 2004, 01:00 ET

Merrimack Pharmaceuticals Begins Exploratory Collaboration with Novartis Institutes for Biomedical Research

CAMBRIDGE, Mass., June 1 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., today announced that the Company has initiated an exploratory research...

May 04, 2004, 01:00 ET

Merrimack Pharmaceuticals Closes $28 Million Series C Financing Round

CAMBRIDGE, Mass., May 4 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that it has...

May 04, 2004, 01:00 ET

Merrimack Pharmaceuticals Welcomes Gary L. Crocker to the Board of Directors

CAMBRIDGE, Mass., May 4 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that Gary L. Crocker has joined the company's board of...

Mar 25, 2004, 00:00 ET

Merrimack Pharmaceuticals Awarded Second SBIR Grant

CAMBRIDGE, Mass., March 25 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that it was awarded a Phase I Small Business...

Feb 04, 2004, 00:00 ET

Merrimack Pharmaceuticals Names Dr. Vincent F. Simmon as Chief Operating Officer

CAMBRIDGE, Mass., Feb. 4 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a biotechnology company focused on developing therapeutics in...

Jan 29, 2004, 00:00 ET

Merrimack Pharmaceuticals Awarded SBIR Grant for Cancer Drug Discovery

CAMBRIDGE, Mass., Jan. 29 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that it was awarded a Phase I Small Business...

Nov 19, 2003, 00:00 ET

Merrimack Pharmaceuticals Completes Dosing in Phase I Study of Immunomodulator, MM-093

CAMBRIDGE, Mass., Nov. 19 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the completion of dosing of all volunteers in the...

Jul 29, 2003, 01:00 ET

Merrimack Pharmaceuticals Initiates Phase I Study of Immunomodulator, MM-093

CAMBRIDGE, Mass., July 29 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the initiation of a Phase I study for its...

Apr 02, 2002, 00:00 ET

Merrimack Pharmaceuticals Names Dr. Mark H. Perrone Vice President of Research And Development

CAMBRIDGE, Mass., April 2 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that Mark H. Perrone, Ph.D., has joined the company as...

Mar 26, 2002, 00:00 ET

Merrimack Pharmaceuticals Elects Gary Frashier As Chairman of the Board of Directors

CAMBRIDGE, Mass., March 26 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the election of Gary Frashier as chairman of...

Mar 19, 2002, 00:00 ET

Merrimack Pharmaceuticals Welcomes Robert H. Rubin, MD to the Board of Directors

CAMBRIDGE, Mass., March 19 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the election of Robert H. Rubin, MD to the company's...

Feb 26, 2002, 00:00 ET

U.S. Composition-of-Matter Patent Secures Merrimack Pharmaceuticals' Rights to Recombinant Human Alpha Fetoprotein

CAMBRIDGE, Mass., Feb. 26 /PRNewswire/ -- Merrimack Pharmaceuticals announced today that the U.S. Patent and Trademark Office has issued a...

Feb 20, 2002, 00:00 ET

Merger Closes Between Merrimack Pharmaceuticals and Atlantic Biopharmaceuticals

CAMBRIDGE, Mass., Feb. 20 /PRNewswire/ -- Atlantic BioPharmaceuticals, Inc. (ABI), an immunology-focused drug development company, and Merrimack...